Can adaptive clinical trials help to solve the productivity crisis of the pharmaceutical industry? - a scenario analysis

AIM: The productivity of pharmaceutical research and development (R&D) investments is declining due to high failure rates in clinical research. Recently, the US Food and Drug Administration (FDA) acknowledged that adaptive designs can make drug development more efficient and less costly. Our obj...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahlich, Jörg, Bartol, Arne, Dheban, Srirangan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811738/
https://www.ncbi.nlm.nih.gov/pubmed/33454837
http://dx.doi.org/10.1186/s13561-021-00302-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811738/
https://www.ncbi.nlm.nih.gov/pubmed/33454837
http://dx.doi.org/10.1186/s13561-021-00302-6

Ejemplares similares